Data / New clinical trials / Multiple Sclerosis

Multiple Sclerosis trials: 477 new since Nov 2024

Name: New Multiple Sclerosis clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Multiple Sclerosis clinical trials: 477 rows for $23.85, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 23 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/multiple-sclerosis, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

477 clinical studies in Multiple Sclerosis were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 55 have an industry sponsor and 299 are recruiting or about to. The newest, NCT07924410, was posted on November 9, 2026: Tele-rehabilitation Program in People With Multiple Sclerosis and Mild Disability (IRCCS San Raffaele Roma).

The request: Every new Multiple Sclerosis clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

477New trials
55Industry sponsored
299Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 477, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07924410	Tele-rehabilitation Program in People With Multiple Sclerosis and Mild Disability	IRCCS San Raffaele Roma	Not applicable	Active not recruiting	Multiple Sclerosis, Fatigue in Multiple Sclerosis	120	Italy	clinicaltrials.gov
November 6, 2026	NCT07923201	Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing...	Casa Colina Hospital and Centers for Healthcare	Not applicable	Not yet recruiting	Stroke, Parkinson's Disease (PD), Spinal Cord Injury, Multiple Sclerosis, Orthopedic Injury	20	United States	clinicaltrials.gov
November 5, 2026	NCT07918339	Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis	Cairo University	Not applicable	Recruiting	Multiple Sclerosis	54	Egypt	clinicaltrials.gov
November 3, 2026	NCT07914257	Non-invasive Brain Stimulation to Improve Memory in Multiple Sclerosis	The University of Texas at Dallas	Not applicable	Not yet recruiting	Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis (RRMS)	80	United States	clinicaltrials.gov
October 28, 2026	NCT07902479	Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health	Institut National de la Santé Et de la Recherche Médicale, France	Not applicable	Not yet recruiting	Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, MOG Antibody-Associated Disease, Demyelinating Autoimmune...	500	France	clinicaltrials.gov
October 27, 2026	NCT07899502	REAL-MS: Observational Database Study of AHSCT and MS Therapies	Imperial College London	Observational	Recruiting	Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Primary Progressive	2,000	United Kingdom	clinicaltrials.gov
October 27, 2026	NCT07899411	Evaluation of the Effect of Mental Imagery Training Combined With Modified Constraint-Induced Movement Therapy in Individuals With Multiple...	Hacettepe University	Not applicable	Not yet recruiting	Multiple Sclerosis	14	Turkey (Türkiye)	clinicaltrials.gov
October 27, 2026	NCT07898371	A Study to Describe Multiple Sclerosis Patients Treated With Tolebrutinib as Per Label in a Real-world Setting	Sanofi	Observational	Recruiting	Multiple Sclerosis	3,000	United Arab Emirates	clinicaltrials.gov
October 27, 2026	NCT07897760	Evaluating the Effects of the EXOPULSE Suit on Mobility, Walking Ability, and Balance in People With Multiple Sclerosis	Otto Bock Healthcare Products GmbH	Not applicable	Not yet recruiting	Multiple Sclerosis	100	Germany, United States	clinicaltrials.gov
October 26, 2026	NCT07893925	The Effects of Synchronous and Asynchronous Pilates Training Based on Telerehabilitation on Core Stabilization, Balance, Cognitive...	Yuzuncu Yil University	Not applicable	Recruiting	Multiple Sclerosis	38	Turkey (Türkiye)	clinicaltrials.gov
October 23, 2026	NCT07891520	Efficacy of Seated Physical Activity INtervention(SPIN) for Wheelchair Users With Multiple Sclerosis	The University of Texas Health Science Center, Houston	Not applicable	Not yet recruiting	Multiple Sclerosis	100	United States	clinicaltrials.gov
October 23, 2026	NCT07890974	Tai Chi Training for Persons With Multiple Sclerosis.	Karolinska Institutet	Not applicable	Active not recruiting	Multiple Sclerosis (MS) - Relapsing-remitting	35	Sweden	clinicaltrials.gov
October 22, 2026	NCT07889271	Hand Grip Strength Correlates Strongly With Weekly Working Hours - the Importance of Upper Limb Function in Multiple Sclerosis	Salzburger Landeskliniken	Observational	Completed	Multiple Sclerosis	300	Austria	clinicaltrials.gov
October 19, 2026	NCT07880418	Ai-Chi in Individuals With Multiple Sclerosis	Kirsehir Ahi Evran Universitesi	Not applicable	Completed	Multiple Sclerosis	20	Turkey (Türkiye)	clinicaltrials.gov
October 19, 2026	NCT07879950	Local Vibration and Ankle Mobilization in Multiple Sclerosis	Gaziantep Islam Science and Technology University	Not applicable	Not yet recruiting	Multiple Sclerosis	60		clinicaltrials.gov
October 16, 2026	NCT07878702	Dual-Task Balance Training in People With Multiple Sclerosis: a Randomized Feasibility Study	Universita di Verona	Not applicable	Not yet recruiting	Multiple Sclerosis	30	Italy	clinicaltrials.gov
October 15, 2026	NCT07875309	An Online Tailored Cognitive Therapy-Based Intervention for Depression in Multiple Sclerosis: ACTION-MS Online	University of Melbourne	Not applicable	Not yet recruiting	Depression and Anxiety Symptoms, Multiple Sclerosis	240	Australia, Canada	clinicaltrials.gov
October 9, 2026	NCT07868887	Validity and Reliability of the Language Memory Test (LMT) in Belgium	Universitair Ziekenhuis Brussel	Observational	Not yet recruiting	Multiple Sclerosis	200		clinicaltrials.gov
October 2, 2026	NCT07856485	Bridging Gaps in the Multidimensional Assessment and Management of Overlapping Symptoms in Multiple Sclerosis and Functional Motor...	IRCCS San Raffaele	Not applicable	Not yet recruiting	Multiple Sclerosis, Functional Neurological Disorders	192	Italy	clinicaltrials.gov
October 2, 2026	NCT07854691	Jacobson's Progressive Muscle Relaxation for Fatigue and Kinesiophobia in Multiple Sclerosis	Al-Zaytoonah University of Jordan	Not applicable	Completed	Multiple Sclerosis	70	Egypt	clinicaltrials.gov
October 1, 2026	NCT07852156	Cooling During Inpatient Rehabilitation in Persons With MS	Klinik Valens	Not applicable	Recruiting	Multiple Sclerosis, Heat Tolerance, Fatigue Symptom	42	Switzerland	clinicaltrials.gov
September 30, 2026	NCT07849816	Assessment of the Frequency of Functional Neurological Disorders in Multiple Sclerosis and Analysis of Clinical and Psychological...	University Hospital, Strasbourg, France	Observational	Not yet recruiting	Functional Neurological Disorders, Multiple Sclerosis	100		clinicaltrials.gov
September 29, 2026	NCT07847853	Inductive Therapeutic Exercise in Multiple Sclerosis	Fundación San Juan De Dios	Not applicable	Not yet recruiting	Multiple Sclerosis	30	Spain	clinicaltrials.gov
September 29, 2026	NCT07847086	Gait Pattern and Its Relation to Cognition and VEP in Multiple Sclerosis	Assiut University	Observational	Not yet recruiting	Multiple Sclerosis, Gait Disorders, Neurologic	70		clinicaltrials.gov
September 29, 2026	NCT07846943	Epstein-Barr Virus Antibodies in Egyptian Patients With Multiple Sclerosis	Assiut University	Observational	Not yet recruiting	Multiple Sclerosis, Epstein-Barr Virus Infections, Epstein-Barr Virus (EBV) Infection	140		clinicaltrials.gov
September 28, 2026	NCT07844070	A Study of Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy	Novartis Pharmaceuticals	Observational	Active not recruiting	Multiple Sclerosis	2,607	United States	clinicaltrials.gov
September 25, 2026	NCT07842744	Multiple Sclerosis Severity and Caregiver Health Outcomes	Süleyman Korkusuz	Observational	Not yet recruiting	Multiple Sclerosis, Caregiver Burden, Sleep Quality, Physical Activity, Psychological Stress	68	Turkey (Türkiye)	clinicaltrials.gov
September 25, 2026	NCT07842731	Investigation of the Prevalence of Sarcopenia and Dynapenia According to Disease Stage in Patients With Multiple Sclerosis and Evaluation...	Atılım University	Observational	Not yet recruiting	Multiple Sclerosis, Sarcopenia, Dynapenia	150	Turkey (Türkiye)	clinicaltrials.gov
September 25, 2026	NCT07842302	Fighting Fatigue in Multiple Sclerosis: TMS vs. tDCS Efficacy.	Universitat Oberta de Catalunya	Not applicable	Not yet recruiting	Multiple Sclerosis	80		clinicaltrials.gov
September 25, 2026	NCT07840924	The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis	Wageningen University	Phase 2	Completed	Sleep Quality, Multiple Sclerosis, Insomnia	16	Netherlands	clinicaltrials.gov
September 25, 2026	NCT07840326	A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)	Sundance Biosciences, Inc.	Phase 2	Recruiting	Primary Progressive Multiple Sclerosis, Primary Progressive MS, Primary Progressive Multiple Sclerosis (PPMS)...	20	United States	clinicaltrials.gov
September 23, 2026	NCT07837050	Use of a Portable Pupillometer to Detect Optic Nerve Impairment in Patients With Suspected Multiple Sclerosis	Centre Hospitalier Universitaire de Nice	Not applicable	Not yet recruiting	Demyelinating Diseases	100		clinicaltrials.gov
September 21, 2026	NCT07831239	Association Between Peripheral Immune Biomarkers and Functional Performance in Multiple Sclerosis	Halic University	Observational	Completed	MS (Multiple Sclerosis)	20	Turkey (Türkiye)	clinicaltrials.gov
September 21, 2026	NCT07829822	Exploring Reproductive Decision-Making Among Women With Multiple Sclerosis	Assiut University	Observational	Not yet recruiting	Multiple Sclerosis	272		clinicaltrials.gov
September 18, 2026	NCT07827716	A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis	Chuan Qin	Phase 2	Recruiting	Relapsing Remitting Multiple Sclerosis	100	China	clinicaltrials.gov
September 17, 2026	NCT07826689	A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis	Progentos Therapeutics	Phase 1/2	Recruiting	Multiple Sclerosis	160	Australia	clinicaltrials.gov
September 17, 2026	NCT07826221	Prevalence of Primary Headache in Multiple Sclerosis Patients	Assiut University	Observational	Not yet recruiting	Multiple Sclerosis, Primary Headache Disorders, Migraine Disorders, Tension-Type Headache	100		clinicaltrials.gov
September 17, 2026	NCT07825389	C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Progressive Multiple Sclerosis...	AbelZeta Inc.	Phase 1/2	Not yet recruiting	Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progress Multiple Sclerosis (SPMS), Primary...	119	United States	clinicaltrials.gov
September 15, 2026	NCT07821411	A Real-World Study of Ofatumumab in Multiple Sclerosis Patients in Germany and Japan	Novartis Pharmaceuticals	Observational	Active not recruiting	Multiple Sclerosis	5,000	Switzerland	clinicaltrials.gov
September 14, 2026	NCT07818356	Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica...	University Hospital, Toulouse	Phase 4	Not yet recruiting	Vaccine, Varicella-zoster Virus, Multiple Sclerosis, Spectrum Disease Neuromyelitis Optica	160	France	clinicaltrials.gov
September 11, 2026	NCT07815990	Aerobic Fitness in Multiple Sclerosis: The Relationship Between Balance and Sensory Dual-Tasking	Suleyman Demirel University	Observational	Recruiting	Multiple Sclerosis	70	Turkey (Türkiye)	clinicaltrials.gov
September 9, 2026	NCT07809828	Driving Performance in Parkinson's Disease and Multiple Sclerosis Using a Driving Simulator	University Hospital Olomouc	Observational	Not yet recruiting	Parkinson, Multiple Sclerosis	100		clinicaltrials.gov
September 4, 2026	NCT07805850	Monitoring Intensity During Balance Training in Persons With Multiple Sclerosis	Klinik Valens	Not applicable	Recruiting	Multiple Sclerosis, Balance	60	Switzerland	clinicaltrials.gov
September 4, 2026	NCT07805733	Early Symptoms in Multiple Sclerosis: an Investigation Using fMRI and Gait Analysis to Develop Personalized Balance Training for People...	LIFE - Research and Care Institute - Santa Lucia IRCCS	Not applicable	Not yet recruiting	Multiple Sclerosis	30		clinicaltrials.gov
September 4, 2026	NCT07805473	[18F]F-DED PET Imaging of Reactive Astrocytes in Multiple Sclerosis	Parc de Salut Mar	Not applicable	Not yet recruiting	Multiple Sclerosis	30	Spain	clinicaltrials.gov
September 4, 2026	NCT07804264	Short Sprint Interval Training in People With Multiple Sclerosis	Universidad de León	Not applicable	Completed	Multiple Sclerosis	40	Spain	clinicaltrials.gov
September 3, 2026	NCT07803523	Kinesiophobia Associated With Fatigue in Patients With Multiple Sclerosis.	Dokuz Eylul University	Observational	Completed	Kinesiophobia, Multiple Sclerosis	352	Turkey (Türkiye)	clinicaltrials.gov
September 2, 2026	NCT07800039	Clinical Pilates for Balance and Function in Multiple Sclerosis	University of Patras	Not applicable	Completed	Multiple Sclerosis	21	Greece	clinicaltrials.gov
August 27, 2026	NCT07789171	Synbiotic Supplementation as a Part of Dietary Modification in Multiple Sclerosis	Hacettepe University	Not applicable	Completed	Multiple Sclerosis (MS) - Relapsing-remitting	38	Turkey (Türkiye)	clinicaltrials.gov
August 27, 2026	NCT07788859	Reliability and Validity of Three DT-TUG Protocols in MS	Afyonkarahisar Health Sciences University	Observational	Recruiting	Multiple Sclerosis	40	Turkey (Türkiye)	clinicaltrials.gov
August 26, 2026	NCT07788573	The Role of the FCRL5 Protein in the Pathophysiology of Multiple Sclerosis and Response to Treatment	Université Catholique de Louvain	Observational	Not yet recruiting	Multiple Sclerosis	90	Belgium	clinicaltrials.gov
August 26, 2026	NCT07786987	Cone Evasion Walk Test in Multiple Sclerosis	Hacettepe University	Observational	Not yet recruiting	Multiple Sclerosis, Pain Management, Function	50	Turkey (Türkiye)	clinicaltrials.gov
August 26, 2026	NCT07786506	Intermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple Sclerosis	Comenius University	Not applicable	Not yet recruiting	Multiple Sclerosis, Muscle Spasticity, Neuropathic Pain	40	Slovakia	clinicaltrials.gov
August 24, 2026	NCT07783074	Fatigue Investigation Using Digital Outcomes	Liliana Barrios	Observational	Recruiting	Multiple Sclerosis, Long Covid, Healthy	122	Switzerland	clinicaltrials.gov
August 21, 2026	NCT07779460	A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice	Novartis Pharmaceuticals	Observational	Recruiting	Multiple Sclerosis	7,466	United States	clinicaltrials.gov
August 20, 2026	NCT07776743	A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis	Guangzhou Lupeng Pharmaceutical Company LTD.	Phase 2	Recruiting	Relapsing-remitting Multiple Sclerosis (RRMS)	30	China	clinicaltrials.gov
August 18, 2026	NCT07771868	High-Intensity Interval Training for Walking and Function Across Different Multiple Sclerosis Disability Levels	Hacettepe University	Not applicable	Recruiting	MULTIPL SCLEROSİS	30	Turkey (Türkiye)	clinicaltrials.gov
August 18, 2026	NCT07770620	Effects of Face-to-Face Versus Telerehabilitation-Based Circuit Training in People With Multiple Sclerosis	Istanbul University - Cerrahpasa	Not applicable	Not yet recruiting	Multiple Sclerosis	36	Turkey (Türkiye)	clinicaltrials.gov
August 17, 2026	NCT07769294	PLasmatic Extracellular Vesicles AS Biomarkers of nEural Tissue Damage	Roberto Furlan	Observational	Not yet recruiting	Multiple Sclerosis, Stroke	60		clinicaltrials.gov
August 17, 2026	NCT07768761	Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis	Louis Stokes VA Medical Center	Not applicable	Recruiting	Spinal Cord Injury/Disorder, Stroke, Multiple Sclerosis, Traumatic Brain Injury	60	United States	clinicaltrials.gov
August 14, 2026	NCT07766213	Pain Phenotypes in Individuals With Multiple Sclerosis	Kutahya Health Sciences University	Observational	Recruiting	Multiple Sclerosis, Chronic Pain	60	Turkey (Türkiye)	clinicaltrials.gov
August 14, 2026	NCT07765212	Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)	Eva M.M. Strijbis	Phase 2	Not yet recruiting	Multiple Sclerosis	75		clinicaltrials.gov
August 13, 2026	NCT07762326	Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis	Cairo University	Not applicable	Not yet recruiting	Multiple Sclerosis	40		clinicaltrials.gov
August 13, 2026	NCT07762040	Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple Sclerosis	Assiut University	Observational	Not yet recruiting	Multiple Sclerosis	180	Egypt	clinicaltrials.gov
August 12, 2026	NCT07759115	Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study	University of Texas at Austin	Not applicable	Recruiting	Multiple Sclerosis, Pathologic Processes, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous...	64	United States	clinicaltrials.gov
August 11, 2026	NCT07758270	Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.	Washington University School of Medicine	Observational	Recruiting	Multiple Sclerosis (MS) - Relapsing-remitting	15	United States	clinicaltrials.gov
August 10, 2026	NCT07756268	Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis	Tongji Hospital	Phase 1/2	Not yet recruiting	Multiple Sclerosis	25	China	clinicaltrials.gov
August 10, 2026	NCT07753928	MS-Related Disability Worsening and Thalamic Volume Loss	Jung Diagnostics GmbH	Observational	Enrolling by invitation	Multiple Sclerosis	2,400	Germany	clinicaltrials.gov
August 6, 2026	NCT07748637	A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis	Daishi Tian	Early phase 1	Not yet recruiting	Multiple Sclerosis (MS)	12	China	clinicaltrials.gov
August 3, 2026	NCT07743281	A Study of Treatment Patterns and Annualized Relapse Rate in Multiple Sclerosis Patients Who Escalate Versus Continue Disease-Modifying...	Novartis Pharmaceuticals	Observational	Completed	Multiple Sclerosis	753	United States	clinicaltrials.gov
August 3, 2026	NCT07742579	Online Mindfulness-Based Cognitive Therapy for People With Multiple Sclerosis With Mild-Moderate Depression	Robert Simpson	Phase 3	Not yet recruiting	Multiple Sclerosis	152		clinicaltrials.gov
August 3, 2026	NCT07741864	Effectiveness of a Mindfulness-Based Intervention for Pain Management in Patients With Multiple Sclerosis (MPIMS).	Hospital Universitario Virgen Macarena	Not applicable	Not yet recruiting	Multiple Sclerosis, Pain, Pain Management	84	Spain	clinicaltrials.gov
July 31, 2026	NCT07738978	Understanding and Enhancing Human Health and Movement	Louis Stokes VA Medical Center	Not applicable	Recruiting	Spinal Cord Injury, Stroke (CVA) or Transient Ischemic Attack, Multiple Sclerosis	75	United States	clinicaltrials.gov
July 31, 2026	NCT07738120	Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis: ExeRVIEM III	University of Vigo	Not applicable	Recruiting	Multiple Sclerosis, Exercise, Physical Therapy, Virtual Reality Exposure Therapy, Rehabilitation Exercise	30	Spain	clinicaltrials.gov
July 30, 2026	NCT07736482	Relationship Between Single- and Dual-Task Obstacle Crossing Performance and Fatigue and Disability in Multiple Sclerosis	Afyonkarahisar Health Sciences University	Observational	Recruiting	Multiple Sclerosis	30	Turkey (Türkiye)	clinicaltrials.gov
July 29, 2026	NCT07735325	Effects of Sensorimotor Insoles on Stability and Gait in Patients With Multiple Sclerosis.	University of Salamanca	Not applicable	Active not recruiting	Multiple Sclerosis	50	Spain	clinicaltrials.gov
July 29, 2026	NCT07734675	Sociocognitive Intervention and Rehabilitation Program in Multiple Sclerosis	Sonia Batista	Not applicable	Not yet recruiting	Multiple Sclerosis	130	Portugal	clinicaltrials.gov
July 29, 2026	NCT07732907	Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia	Bristol-Myers Squibb	Observational	Recruiting	Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy	15	United States	clinicaltrials.gov
July 28, 2026	NCT07731659	Physical Activity Intervention for Individuals Newly Diagnosed With MS	University of Illinois Chicago	Not applicable	Not yet recruiting	Multiple Sclerosis	50	United States	clinicaltrials.gov
July 24, 2026	NCT07726667	Effects of CTAR and PNF Exercises on Swallowing in Multiple Sclerosis	Sanko University	Not applicable	Completed	Multiple Sclerosis, Dysphagia, Deglutition Disorders	39	Turkey (Türkiye)	clinicaltrials.gov
July 23, 2026	NCT07724093	Effects of Powered Hip Flexion Device in Persons With Multiple Sclerosis	University of Dayton	Not applicable	Not yet recruiting	Multiple Sclerosis (MS) Relapsing Remitting	10	United States	clinicaltrials.gov
July 23, 2026	NCT07723599	Combating Age-related Failure of Myelination in Multiple Sclerosis: An Exploratory Study	University of Washington	Observational	Not yet recruiting	Multiple Sclerosis	14	United States	clinicaltrials.gov
July 22, 2026	NCT07720765	Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)	IRCCS San Raffaele	Observational	Recruiting	Multiple Sclerosis, Alzheimer Disease, Parkinson Disease, Migraine, Headache Disorders	1,050	Italy	clinicaltrials.gov
July 17, 2026	NCT07710742	Effects Of Motor Imagery and Sensorimotor Training	Uludag University	Not applicable	Not yet recruiting	Multiple Sclerosis	51	Turkey (Türkiye)	clinicaltrials.gov
July 17, 2026	NCT07710105	Ocrevus Zunovo for MS: Mixed Methods	Northwestern University	Observational	Recruiting	Multiple Sclerosis	150	United States	clinicaltrials.gov
July 15, 2026	NCT07706114	FES: Effect on Walking in the Real World and Participation in Daily Life in People With Multiple Sclerosis.	University of California, San Francisco	Not applicable	Enrolling by invitation	Multiple Sclerosis	70	United States	clinicaltrials.gov
July 15, 2026	NCT07705581	Validation and Standardization of Paramagnetic Rim Lesion (PRL) Identification in Multiple Sclerosis Across MAGNIMS Centers	IRCCS San Raffaele	Observational	Active not recruiting	Multiple Sclerosis	1,402	Austria, Czechia, Denmark, Germany, Italy, Netherlands, Norway, Spain, Sweden...	clinicaltrials.gov
July 15, 2026	NCT07704294	Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool	King's College London	Observational	Not yet recruiting	Optic Neuritis, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein...	180	United Kingdom	clinicaltrials.gov
July 8, 2026	NCT07689682	OPM- MEG in Non-immune And iMmune-medIated Neurological Disease	Aston University	Not applicable	Recruiting	Autoimmune Encephalitis (AE), Acute Disseminated Encephalomyelitis, Multiple Sclerosis	90	United Kingdom	clinicaltrials.gov
July 7, 2026	NCT07687693	Simultaneous T2-FLAIR and T1 Brain MRI With ENRAGED FLAIR in Multiple Sclerosis	Region Stockholm	Not applicable	Completed	Multiple Sclerosis	11	Sweden	clinicaltrials.gov
July 2, 2026	NCT07681037	The Impact of Good Versus Poor Sleep Quality on Quality of Life, Depression, and Fatigue in Individuals With Multiple Sclerosis	Trakya University	Observational	Completed	Quality of Life, Depression, Multiple Sclerosis	121	Turkey (Türkiye)	clinicaltrials.gov
July 2, 2026	NCT07680738	Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis	Universidad de Almeria	Not applicable	Completed	Multiple Sclerosis, MS, Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS)...	38	Mexico	clinicaltrials.gov
July 2, 2026	NCT07680361	Study of Home Use of the Jaco Robotic Manipulation Device by Individuals With Tetraplegia	Association APPROCHE	Not applicable	Completed	Tetraplegia, Functional Tetraplegia, Spinal Cord Injury, Muscular Dystrophy, ALS (Amyotrophic Lateral Sclerosis)...	18	France	clinicaltrials.gov
July 1, 2026	NCT07680049	The Mediating Role of Balance in the Relationship Between Fatigue and Fear of Falling in Individuals With Multiple Sclerosis	Uskudar University	Observational	Completed	Multiple Sclerosis	40	Turkey (Türkiye)	clinicaltrials.gov
June 30, 2026	NCT07676266	A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy	The Affiliated Hospital of Qingdao University	Phase 1	Not yet recruiting	Multiple Sclerosis (MS), Myasthenia Gravis (MG), Neuromyelitis Optica Spectrum Disorder, Systemic Lupus Erythematosus...	18	China	clinicaltrials.gov
June 29, 2026	NCT07673354	Home-based Spinal Cord Stimulation for Hand & Arm Function in MS	University of Washington	Not applicable	Enrolling by invitation	Multiple Sclerosis	2	United States	clinicaltrials.gov
June 29, 2026	NCT07672535	Inspiratory Muscle Training in Individuals With Multiple Sclerosis	Istanbul University - Cerrahpasa	Not applicable	Not yet recruiting	Multiple Sclerosis, Inspiratory Muscle Training	48		clinicaltrials.gov
June 25, 2026	NCT07667322	A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation...	Hoffmann-La Roche	Phase 1	Active not recruiting	Multiple Sclerosis	75	Brazil, Mexico, United Kingdom, United States	clinicaltrials.gov
June 24, 2026	NCT07666958	Comprehensive Rehabilitation Programme in People With Multiple Sclerosis: The RECONNECT-MS Study	Charles University, Czech Republic	Not applicable	Not yet recruiting	Multiple Sclerosis	45	Czechia	clinicaltrials.gov
June 23, 2026	NCT07663266	Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury	University of Michigan	Observational	Completed	Multiple Sclerosis, Spinal Cord Injury	10	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Cairo University	10	November 5, 2026
Assiut University	10	September 29, 2026
Hacettepe University	9	October 27, 2026
Novartis Pharmaceuticals	9	September 28, 2026
Sanko University	8	July 24, 2026
University Hospital, Strasbourg, France	5	September 30, 2026
University of Washington	5	July 23, 2026
Hunter College of City University of New York	5	April 27, 2026
Ondokuz Mayıs University	5	April 17, 2026
Firat University	5	April 13, 2026
Tongji Hospital	4	August 10, 2026
Gazi University	4	March 20, 2026
IRCCS Centro Neurolesi Bonino Pulejo	4	February 3, 2026
The University of Texas Health Science Center, Houston	3	October 23, 2026
Universita di Verona	3	October 16, 2026
IRCCS San Raffaele	3	October 2, 2026
Daishi Tian	3	August 6, 2026
University of Illinois Chicago	3	July 28, 2026
Northwestern University	3	July 17, 2026
University of California, San Francisco	3	July 15, 2026

By phase

Phase	New trials	Latest
Not applicable	245	November 9, 2026
Observational	153	October 27, 2026
Phase 2	24	September 25, 2026
Phase 1	21	June 30, 2026
Phase 1/2	9	September 17, 2026
Early phase 1	9	August 6, 2026
Phase 4	8	September 14, 2026
Phase 3	8	August 3, 2026

By country

Country	New trials	Latest
United States	99	November 6, 2026
Turkey (Türkiye)	95	October 27, 2026
Italy	38	November 9, 2026
Spain	38	September 29, 2026
France	28	October 28, 2026
China	23	September 18, 2026
United Kingdom	19	October 27, 2026
Egypt	15	November 5, 2026
Germany	15	October 27, 2026
Switzerland	13	October 1, 2026
Belgium	12	August 26, 2026
Canada	11	October 15, 2026
Sweden	10	October 23, 2026
Denmark	9	July 15, 2026
Australia	8	October 15, 2026
Czechia	8	July 15, 2026
Netherlands	7	September 25, 2026
Brazil	6	June 25, 2026
Austria	5	October 22, 2026
Greece	5	September 2, 2026
Portugal	5	July 29, 2026
Mexico	5	July 2, 2026
Poland	5	March 31, 2026
Israel	5	December 30, 2025
United Arab Emirates	4	October 27, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.